FY2024 Earnings Estimate for RPID Issued By KeyCorp

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Free Report) - Research analysts at KeyCorp issued their FY2024 earnings per share (EPS) estimates for shares of Rapid Micro Biosystems in a note issued to investors on Tuesday, February 11th. KeyCorp analyst P. Knight expects that the company will earn ($1.10) per share for the year. KeyCorp has a "Strong-Buy" rating on the stock. The consensus estimate for Rapid Micro Biosystems' current full-year earnings is ($1.09) per share. KeyCorp also issued estimates for Rapid Micro Biosystems' Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($0.97) EPS and FY2026 earnings at ($0.82) EPS.

Rapid Micro Biosystems Stock Up 12.1 %

Shares of RPID stock traded up $0.42 during mid-day trading on Friday, reaching $3.90. The stock had a trading volume of 917,754 shares, compared to its average volume of 410,897. The firm's 50 day simple moving average is $1.61 and its 200 day simple moving average is $1.18. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.00. The firm has a market cap of $167.82 million, a PE ratio of -3.48 and a beta of 1.26.

Institutional Investors Weigh In On Rapid Micro Biosystems

Hedge funds and other institutional investors have recently bought and sold shares of the business. Millennium Management LLC increased its holdings in Rapid Micro Biosystems by 17.6% during the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after purchasing an additional 9,191 shares in the last quarter. Citadel Advisors LLC acquired a new stake in Rapid Micro Biosystems during the 4th quarter valued at $65,000. Finally, Renaissance Technologies LLC increased its holdings in Rapid Micro Biosystems by 122.9% during the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after purchasing an additional 100,942 shares in the last quarter. 52.60% of the stock is owned by institutional investors and hedge funds.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.